ישראל -
עברית -
Ministry of Health
atrion inflation device
"a.m.i. technologies, ltd." - רופא - משאבת ניפוח לבלון המיועד לצינתור
ישראל -
עברית -
Ministry of Health
טריקאן 200 מג קפסולות
pfizer pfe pharmaceuticals israel ltd - fluconazole - קפסולות - fluconazole 200 mg - fluconazole - fluconazole - cryptococcosis. systemic candidiasis. mucosal candidiasis. vaginal candidiasis.
ישראל -
עברית -
Ministry of Health
inflation device
intromedix advanced medical technologies ltd - רופא - מערכת ניפוח
ישראל -
עברית -
Ministry of Health
אמיודקור זריקות
sanofi israel ltd - amiodarone hydrochloride - תמיסה להזרקה - amiodarone hydrochloride 50 mg / 1 ml - amiodarone - amiodarone - corronary insufficiency, arrhythmias resistant to other treatments, wolf parkinson white syndrome.
ישראל -
עברית -
Ministry of Health
סטאלבו 10025200 מג
inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.
ישראל -
עברית -
Ministry of Health
סטאלבו 5012.5200 מג
inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.
ישראל -
עברית -
Ministry of Health
רנוולה טבליות 800 מג
sanofi israel ltd - sevelamer carbonate anhydrous - טבליות מצופות פילם - sevelamer carbonate anhydrous 800 mg - sevelamer - sevelamer - for the control of hyperphosphataemia in adult patients receiving haemodialysis or peritoneal dialysis.also indicated for the control of hyperphosphataemia in adult patients with chronic kidney disease not on dialysis with serum phosphorus ? 1.78 mmol/l.should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy vitamin d3 or one of its analogues to control the development of renal bone disease.